- Home
- GORO vs ICCC Comparison
GORO vs ICCC Comparison
Compare GORO & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORO
- ICCC
- Stock Information
- Founded
- GORO 1998
- ICCC 1982
- Country
- GORO United States
- ICCC United States
- Employees
- GORO N/A
- ICCC N/A
- Industry
- GORO Precious Metals
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- GORO Basic Materials
- ICCC Health Care
- Exchange
- GORO Nasdaq
- ICCC Nasdaq
- Market Cap
- GORO 43.4M
- ICCC 39.2M
- IPO Year
- GORO N/A
- ICCC 1987
- Fundamental
- Price
- GORO $0.39
- ICCC $5.02
- Analyst Decision
- GORO Strong Buy
- ICCC
- Analyst Count
- GORO 1
- ICCC 0
- Target Price
- GORO $1.75
- ICCC N/A
- AVG Volume (30 Days)
- GORO 2.4M
- ICCC 4.1K
- Earning Date
- GORO 03-12-2025
- ICCC 02-25-2025
- Dividend Yield
- GORO N/A
- ICCC N/A
- EPS Growth
- GORO N/A
- ICCC N/A
- EPS
- GORO N/A
- ICCC N/A
- Revenue
- GORO $73,897,000.00
- ICCC $23,838,001.00
- Revenue This Year
- GORO N/A
- ICCC N/A
- Revenue Next Year
- GORO $48.90
- ICCC N/A
- P/E Ratio
- GORO N/A
- ICCC N/A
- Revenue Growth
- GORO N/A
- ICCC 46.37
- 52 Week Low
- GORO $0.12
- ICCC $3.34
- 52 Week High
- GORO $0.71
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- GORO 59.83
- ICCC 47.31
- Support Level
- GORO $0.29
- ICCC $4.84
- Resistance Level
- GORO $0.41
- ICCC $5.25
- Average True Range (ATR)
- GORO 0.05
- ICCC 0.27
- MACD
- GORO -0.00
- ICCC -0.04
- Stochastic Oscillator
- GORO 83.67
- ICCC 27.27
About GORO Gold Resource Corporation
Gold Resource Corp is a gold and silver producer, developer, and explorer with operations in Oaxaca, Mexico, and Nevada, USA. It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.